MindWalk Holdings Corp. (HYFT)
| Market Cap | 63.08M +315.0% |
| Revenue (ttm) | 20.70M +95.9% |
| Net Income | -9.03M |
| EPS | -0.20 |
| Shares Out | 49.67M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 246,352 |
| Open | 1.235 |
| Previous Close | 1.200 |
| Day's Range | 1.210 - 1.290 |
| 52-Week Range | 0.437 - 3.246 |
| Beta | 0.65 |
| Analysts | Strong Buy |
| Price Target | 5.00 (+293.7%) |
| Earnings Date | Mar 12, 2026 |
About HYFT
MindWalk Holdings Corp. operates as a bio-native AI company. It focuses on the integration of artificial intelligence, multi-omics data, and advanced laboratory research to accelerate the discovery and development of biologics. The company, through its LensAI platform and HYFT technology, it partners with pharmaceutical and biotechnology companies to drive de-risk drug development and unlock therapeutic possibilities. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 202... [Read more]
Financial Performance
In fiscal year 2025, MindWalk Holdings's revenue was 24.52 million, an increase of 0.01% compared to the previous year's 24.52 million. Losses were -30.23 million, 15.8% more than in 2024.
Financial numbers in CAD Financial StatementsAnalyst Summary
According to one analyst, the rating for HYFT stock is "Strong Buy" and the 12-month stock price target is $5.0.
News
MindWalk initiated with a Buy at JonesResearch
JonesResearch initiated coverage of MindWalk (HYFT) with a Buy rating and $5 price target MindWalk offers an end-to-end ecosystem for drug discovery, but “what sets it apart” is its Bio-Native
MindWalk Holdings Earnings Call Transcript: Q3 2026
Revenue grew 52% YoY in Q3 2026, driven by U.S. expansion and the first recurring LensAI contract. Pipeline programs advanced, cash position remains strong, and asset-level financing is in progress.
MindWalk Holdings Corp. Reports Q3 Fiscal 2026 Financial Results
AUSTIN, Texas--(BUSINESS WIRE)---- $HYFT #ai--MindWalk Holdings Corp. (Nasdaq: HYFT), a Bio-Native AI company focused on biologics discovery and AI-driven drug development, today reported financial re...
MindWalk announces nanobody discovery platform
MindWalk (HYFT) Holdings “announced B Cell Llama(TM), a platform for the discovery of VHH nanobodies: the single-domain antibody fragments increasingly recognized as the ideal molecular building block...
MindWalk Announces B Cell Llama™, a Nanobody Discovery Platform Designed for the Bispecific and Cell Therapy Era
AUSTIN, Texas--(BUSINESS WIRE)---- $HYFT #ai--MindWalk Holdings Corp. (NASDAQ: HYFT), a bio-native AI company, today announced B Cell Llama™, a platform for the discovery of VHH nanobodies: the single...
MindWalk Holdings Corp. to Report Third Quarter Fiscal Year 2026 Financial Results on March 12, 2026
AUSTIN, Texas--(BUSINESS WIRE)--MindWalk Holdings Corp. (NASDAQ:HYFT) (“MindWalk” or the “Company”), a Bio-Native AI therapeutic research and technology company, today announced that it will report fi...
MindWalk Applies HYFT® Technology to Detect Functional Adjacency Linked to Portfolio Risk in AI-Designed Therapeutics
AUSTIN, Texas--(BUSINESS WIRE)--MindWalk Holdings Corp. (NASDAQ:HYFT) (“MindWalk” or the “Company”), a Bio-Native AI therapeutic research and technology company, today announced an application of its ...
MindWalk Validates Platform Precision with Breakthrough Discovery Targeting Pathogenic TDP-43 in Neurodegenerative Disease
VICTORIA, British Columbia--(BUSINESS WIRE)--MindWalk Holdings Corp. (“MindWalk” or the “Company”) (Nasdaq: HYFT) today announced the discovery and validation of monoclonal antibodies and intrabodies ...
REPEAT/MindWalk Advances Universal Influenza Program with a Breakthrough Functional Insight
AUSTIN, Texas--(BUSINESS WIRE)--MindWalk Holdings Corp. (NASDAQ:HYFT) (“MindWalk” or the “Company”), a Bio-Native AI therapeutic research and technology company, today announced an advance in its univ...
MindWalk announces advance in influenza program
MindWalk (HYFT) announced an advance in its universal influenza program following the identification of a functional constraint that persists across influenza viruses despite continual evolution. Mind...
MindWalk Advances Universal Influenza Program with a Breakthrough Functional Insight
AUSTIN, Texas--(BUSINESS WIRE)--MindWalk Holdings Corp. (NASDAQ:HYFT) (“MindWalk” or the “Company”), a Bio-Native AI therapeutic research and technology company, today announced an advance in its univ...
MindWalk Holdings Earnings Call Transcript: Q2 2026
Second quarter saw 54% revenue growth and a 94% increase in gross profit, driven by scalable AI-enabled programs and the divestiture of non-core assets. A strong cash position and new asset portfolio structure support continued investment and protect shareholders from dilution.
MindWalk Reports Record Growth and Announces Strategic Progress on Its AI Asset Pipeline
VICTORIA, British Columbia--(BUSINESS WIRE)---- $HYFT #ai--MindWalk (NASDAQ: HYFT), a BioNative AI biotherapeutic research and technology company combining in silico and wet lab operations for biologi...
MindWalk Holdings Corp. to Report Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2026 on December 15, 2025
AUSTIN, Texas--(BUSINESS WIRE)--MindWalk Holdings Corp. (NASDAQ:HYFT) (“MindWalk” or the “Company”), a Bio-Native AI therapeutic research and technology company, today announced that it will host a co...
MindWalk CTO Dr. Dirk Van Hyfte to Join Fireside Chat at AI Drug Discovery & Development Summit 2025
AUSTIN, Texas--(BUSINESS WIRE)---- $HYFT #AI--MindWalk Holdings Corp.™ (“MindWalk,” “Company,” “we” or “us”) (Nasdaq: HYFT), a Bio-Native AI company, today announced that Dr. Dirk Van Hyfte, Chief Tec...
MindWalk director Kamil Isaev resigns after failing to get majority vote
MindWalk (HYFT) announced the results of its 2025 annual general meeting. In accordance with the company’s majority voting policy, Kamil Isaev, having received approximately 32% of votes in favor and
MindWalk appoints R. Scott Areglado as Chief Financial Officer
MindWalk (HYFT) announced the appointment of industry veteran R. Scott Areglado as CFO, effective October 20. Areglado brings more than 25 years of financial leadership experience across the healthcar...
MindWalk Appoints R. Scott Areglado as Chief Financial Officer to Strengthen Financial Leadership and Support Growth Strategy
AUSTIN, Texas--(BUSINESS WIRE)---- $HYFT #AI--MindWalk Holdings Corp.™ (“MindWalk,” “Company,” “we” or “us”) (Nasdaq: HYFT), bio-native AI company today announces the appointment of industry veteran R...
MindWalk appoints Thomas Lynch as chief business officer
MindWalk (HYFT) announced the appointment of Thomas Lynch as chief business officer, effective October 20. Most recently, Dr. Lynch served as director of technical sales and scientific support at Alde...
MindWalk Appoints Dr. Thomas W. Lynch as Chief Business Officer to Accelerate Commercial Expansion
AUSTIN, Texas--(BUSINESS WIRE)---- $HYFT #AI--MindWalk Holdings Corp.™ (“MindWalk,” “Company,” “we” or “us”) (Nasdaq: HYFT), a Bio-Native AI company today announced the appointment of industry veteran...
MindWalk announces up to 2.3M share stock repurchase program
MindWalk (HYFT) announced that its board of directors has authorized a share repurchase program under which MindWalk may repurchase up to 2.3M common shares of the company, no par value
MindWalk Announces Share Repurchase Program
AUSTIN, Texas--(BUSINESS WIRE)---- $hyft #AI--MindWalk Holdings Corp. (“MindWalk” or the “Company”) (NASDAQ: “HYFT”), a bio-native AI company, today announced that to underscore its confidence in Mind...
MindWalk advances AI-designed GLP-1 therapeutics program
MindWalk (HYFT) announced a major advancement of its AI-designed GLP-1 therapeutics program. New insights from the company’s LensAI platform reveal a previously unrecognized connection between GLP-1 b...
MindWalk Advances AI-Designed GLP-1 Program with First-in-Class Dual-Pathway Regimen for Aging and Longevity
AUSTIN, Texas--(BUSINESS WIRE)---- $HYFT #AI--MindWalk Holdings Corp.™ (“MindWalk,” “Company,” “we” or “us”) (Nasdaq: HYFT), a Bio-Native AI company, today announced a major advancement of its AI-desi...
MindWalk Holdings Earnings Call Transcript: Q1 2026
Record Q1 revenue and margin expansion were achieved, with improved operating results and a strengthened balance sheet following the Netherlands divestiture. The rebranding to MindWalk Inc. and focus on AI-driven platforms position the company for scalable growth and new partnerships.